DK1594520T3 - Use of antagonists of bradykinin B2 receptors for the treatment of osteoarthrosis - Google Patents

Use of antagonists of bradykinin B2 receptors for the treatment of osteoarthrosis

Info

Publication number
DK1594520T3
DK1594520T3 DK04704552T DK04704552T DK1594520T3 DK 1594520 T3 DK1594520 T3 DK 1594520T3 DK 04704552 T DK04704552 T DK 04704552T DK 04704552 T DK04704552 T DK 04704552T DK 1594520 T3 DK1594520 T3 DK 1594520T3
Authority
DK
Denmark
Prior art keywords
osteoarthrosis
bradykinin
antagonists
receptors
treatment
Prior art date
Application number
DK04704552T
Other languages
Danish (da)
Inventor
Martin Michaelis
Karl Rudolphi
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1594520T3 publication Critical patent/DK1594520T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK04704552T 2003-02-07 2004-01-23 Use of antagonists of bradykinin B2 receptors for the treatment of osteoarthrosis DK1594520T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10304994A DE10304994A1 (en) 2003-02-07 2003-02-07 The use of antagonists of the bradykinin B2 receptor for the treatment of osteoarthrosis

Publications (1)

Publication Number Publication Date
DK1594520T3 true DK1594520T3 (en) 2006-12-11

Family

ID=32797325

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04704552T DK1594520T3 (en) 2003-02-07 2004-01-23 Use of antagonists of bradykinin B2 receptors for the treatment of osteoarthrosis

Country Status (31)

Country Link
EP (1) EP1594520B1 (en)
JP (1) JP2006516980A (en)
KR (1) KR20050105447A (en)
CN (1) CN1317029C (en)
AR (1) AR043036A1 (en)
AT (1) ATE335500T1 (en)
AU (1) AU2004210396A1 (en)
BR (1) BRPI0407333A (en)
CA (1) CA2514152C (en)
CO (1) CO5690613A2 (en)
CY (1) CY1105708T1 (en)
DE (2) DE10304994A1 (en)
DK (1) DK1594520T3 (en)
ES (1) ES2268622T3 (en)
HK (1) HK1085926A1 (en)
HR (1) HRP20050701B1 (en)
IL (1) IL169899A0 (en)
MA (1) MA27618A1 (en)
ME (1) MEP41008A (en)
MX (1) MXPA05007310A (en)
MY (1) MY135827A (en)
NO (1) NO333903B1 (en)
NZ (1) NZ541680A (en)
PE (1) PE20040939A1 (en)
PL (1) PL206412B1 (en)
PT (1) PT1594520E (en)
RS (1) RS51029B (en)
RU (1) RU2329057C2 (en)
TW (1) TW200505472A (en)
WO (1) WO2004069266A2 (en)
ZA (1) ZA200505177B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0710522D0 (en) * 2007-06-01 2007-07-11 Royal Veterinary College The Drug delivery system comprising matrix metalloproteinase inhibitors
IT1391236B1 (en) * 2008-07-11 2011-12-01 St Luso Farm D'italia Spa PHARMACEUTICAL COMPOSITIONS BASED ON ANTAGONISTS OF THE B2 KININE AND CORTICOSTEROID RECEPTOR AND THEIR USE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
MX9100717A (en) * 1990-08-24 1992-04-01 Syntex Inc BRADIQUININE ANTAGONISTS
FR2751650B1 (en) * 1996-07-24 1998-10-09 Fournier Ind & Sante NOVEL N-BENZENESULFONYL-L-PROLINE COMPOUNDS, METHOD OF PREPARATION AND THERAPEUTIC USE
CA2364178C (en) * 2000-12-05 2006-01-10 Yasuhiro Katsu N-benzenesulfonyl l-proline compounds as bradykinin antagonists
CA2474645C (en) * 2002-02-01 2011-08-09 Omeros Corporation Compositions and methods for systemic inhibition of cartilage degradation

Also Published As

Publication number Publication date
TW200505472A (en) 2005-02-16
EP1594520A2 (en) 2005-11-16
DE10304994A1 (en) 2004-09-02
HRP20050701A2 (en) 2006-09-30
KR20050105447A (en) 2005-11-04
PL376605A1 (en) 2006-01-09
ATE335500T1 (en) 2006-09-15
HK1085926A1 (en) 2006-09-08
DE502004001159D1 (en) 2006-09-21
MEP41008A (en) 2011-02-10
NZ541680A (en) 2009-07-31
JP2006516980A (en) 2006-07-13
IL169899A0 (en) 2011-08-01
MXPA05007310A (en) 2005-09-30
CO5690613A2 (en) 2006-10-31
CN1317029C (en) 2007-05-23
HRP20050701B1 (en) 2014-01-03
WO2004069266A3 (en) 2004-09-30
AR043036A1 (en) 2005-07-13
CA2514152C (en) 2012-01-17
NO333903B1 (en) 2013-10-14
ES2268622T3 (en) 2007-03-16
MA27618A1 (en) 2005-11-01
RS51029B (en) 2010-10-31
PT1594520E (en) 2006-11-30
ZA200505177B (en) 2006-11-29
RU2329057C2 (en) 2008-07-20
AU2004210396A1 (en) 2004-08-19
CY1105708T1 (en) 2010-12-22
NO20054144L (en) 2005-09-06
CN1747742A (en) 2006-03-15
PE20040939A1 (en) 2005-01-17
RU2005127862A (en) 2006-01-27
EP1594520B1 (en) 2006-08-09
MY135827A (en) 2008-07-31
CA2514152A1 (en) 2004-08-19
WO2004069266A2 (en) 2004-08-19
PL206412B1 (en) 2010-08-31
RS20050565A (en) 2007-09-21
BRPI0407333A (en) 2006-01-10

Similar Documents

Publication Publication Date Title
IS8501A (en) Azate cyclic heterocycles as cannabinonide receptor antagonists
ATE413400T1 (en) CGRP RECEPTOR ANTAGONISTS
DE602005012267D1 (en) N OF DEVICES
DK1643998T3 (en) NK1 / NK3 antagonists for the treatment of schizophrenia
DK3395338T3 (en) QUICK SOLVING FORMULATION OF CINACALCET-HCL
IS7362A (en) Quinazoline compounds
DK1575597T3 (en) Use of rimexolone for the treatment of eye dryness
IL175084A0 (en) Antagonists of the bradykinin b1 receptor
DK1803718T3 (en) 4-Tetrazolyl-4-phenylpiperidine derivatives for the treatment of pain
DK1763520T3 (en) Use of trisubstituted benzopyranones
ATE397618T1 (en) PEPTIDE CYCLIZATION
DE602004019555D1 (en) HETEROCYCLIC 7-AMINOALKYLIDENYLCHINOLONE AND -NAPHTHYRIDONE
IS7833A (en) Combined heterocyclic compounds
DE602005001661D1 (en) surveying equipment
DE602004000143D1 (en) vibratory gyroscope
ATE469875T1 (en) NK1 ANTAGONISTS
IS8278A (en) Cycopropyl derivatives as NK3 receptor antagonists
DK1541137T3 (en) Transdermal delivery system of the gestoden
DE602004030875D1 (en) showerhead
DK1660485T3 (en) Improved process for the preparation of alpha-polymorphic eletriptan hydrobromide
DK1809267T3 (en) Pharmaceutical compositions based on NK2 antagonists for pediatric use
DK1594520T3 (en) Use of antagonists of bradykinin B2 receptors for the treatment of osteoarthrosis
DK1685104T3 (en) Process for the preparation of N-substituted phthalomides
DK1506820T3 (en) Spray device
ATE439379T1 (en) CHIMERIC ANTAGONIST ANTH1